Blood-thinner with no bleeding side-effects is here
In a study led by EPFL, scientists have developed a synthetic blood-thinner that, unlike all others, doesn’t cause bleeding side-effects. The highly potent, highly selective, and highly stable molecule can suppress thrombosis while letting blood clot normally following injury.
"We want to create a narrative out of all the heterogeneous data"
Summer series: A calling for research. Sarah Kenderdine, head of the Laboratory for Experimental Museology in the College of Humanities, has spent the last four years tracing, photographing, and digitally reconstructing the seldom-told story of Buddhism’s maritime spread across Asia.
"It felt like we were living on another planet”
Julia Schmale is a truly adventurous researcher, and her favorite places to explore are extreme environments in far-flung corners of the world. During her most recent trip, she was stranded in the icy Arctic for four months, a long way from COVID-19 but impacted by its effects.
Located in Switzerland, EPFL is one of Europe’s most vibrant and cosmopolitan science and technology institutions.
Through five schools and three colleges, EPFL community tackles the biggest challenges of our time through education, research and innovation.
At the heart of beautiful Switzerland, EPFL is a world of curiosity, collaboration and learning.
EPFL brings together all levels of education and offers innovative training to its 11,500 students. Our advanced training courses for engineers, architects and scientists are adapted to the challenges of our time.
With over 350 laboratories and research groups on campus, EPFL is one of the world’s most innovative and productive scientific institutions. Discover the main actors, projects and services within EPFL’s research community.
EPFL transforms scientific excellence into value for companies and society in general. Its innovation park, which houses 170 companies, creates a unique ecosystem that fosters innovation and entrepreneurship on campus.